
Today the research project BioRescue for the rescue of the Northern White Rhino, which is threatened with extinction, is officially launched. State-of-the-art reproduction and stem cell technology shall ensure the survival of this key species. The international scientific consortium, led by the Leibniz Institute for Zoo and Wildlife Research (Leibniz-IZW) and with the significant participation of the Max Delbrück Center for Molecular Medicine (MCD), is receiving around 4 million Euros in funding from the Federal Ministry of Education and Research (BMBF) as part of the BMBF's biodiversity conservation research initiative. With the successful transfer of an embryo into the uterus of a Southern white rhinoceros at the end of May 2019, the research team has already reached an important milestone. The ethical and social questions arising from BioRescue will be addressed by the scientists in an accompanying research project.

Najin and Fatu, the last two remaining Northern White Rhinoceroses. | Photo by Jan Stejskal
Upon the launch of the project, Dr. Michael Meister, Parliamentary State Secretary to the Federal Minister of Education and Research, said: “Biodiversity provides the basis for our livelihoods. The Federal Ministry of Education and Research has therefore established the Research Initiative for the Preservation of Biodiversity. Within this initiative, we primarily focus on promoting precautionary research aimed at preserving biodiversity. Parallel to this, we also facilitate immediate measures to protect endangered species, such as the ambitious BioRescue project. Thanks to the impressive combination of different research approaches and the great dedication shown by those involved, there is now both the possibility and the hope that we will be able to preserve critically endangered species such as the northern white rhinoceros.”
“The BioRescue research project can play an important role in the conservation of species diversity because it significantly advances existing approaches for species conservation,” says project leader Prof. Thomas Hildebrandt from the Leibniz-IZW. The international team of experts from Germany, Italy, the Czech Republic, Japan and the USA will jointly develop methods and techniques for reproduction and stem cell research. These are being used for the first time to save an endangered animal species.
“The BioRescue project is a perfect example for the excellent and relevant research of the Leibniz Association. An interdisciplinary and international research team transfers its findings and methods directly into application and thus helps to save a valuable key species such as the Northern White Rhino from extinction”, says Prof. Matthias Kleiner, President of the Leibniz Association.
The situation for the Northern White Rhino is particularly critical: after the death of the last bull, Sudan, in March 2018, only two females remain: Najin and Fatu. They live in the Ol Pejeta Conservancy in Kenya. The team of experts is pursuing two approaches to save this important species:
The BioRescue project attempts to push the boundaries of what is medically and technically feasible for the benefit of species conservation. This raises ethical questions regarding the use of the newly created possibilities. These questions will be openly discussed in the BioRescue project: Prof. Barbara De Mori heads the Ethics Laboratory for Veterinary Medicine, Conservation and Animal Welfare at the University of Padua (Italy) and is responsible for research on ethical questions in the fields of medicine, technology and society in the BioRescue project. In this context, the consortium will actively promote public debate in order to find answers to the ethical responsibility of scientists, governments and the public for the conservation of biodiversity.
As a strong African partner, the Kenyan government plays a central role in saving the Northern White Rhinoceros. The Republic of Kenya's exemplary biodiversity policy is a backbone for the sustainability of African biodiversity. The fact that the Kenyan government - as a network partner - attaches great importance to the BioRescue project is demonstrated by the participation of the Ambassador of Kenya, His Excellency Joseph Magutt, at today's press conference.
With its funding of BioRescue, the BMBF supports the German network partners. Research needs that are not covered by BMBF funding are met by the international consortium partners and generously provided by external donors and supporters from industry, such as the science and technology company Merck, and the private sector. “We are embracing our responsibility as leaders in fertility by providing innovative technologies to give this ambitious project the best chance at success,” says Dr. Jan Kirsten, Head of Global Business Franchise for Fertility, Merck.